首页 | 本学科首页   官方微博 | 高级检索  
检索        

类黄酮细胞周期蛋白依赖性激酶抑制剂的合成与抗癌活性研究
引用本文:李艳玲,方浩,徐文方.类黄酮细胞周期蛋白依赖性激酶抑制剂的合成与抗癌活性研究[J].包头医学院学报,2011,27(4):12-14.
作者姓名:李艳玲  方浩  徐文方
作者单位:山东大学药学院,山东济南250012;包头医学院药学院;山东大学药学院,山东济南,250012
基金项目:以金属蛋白酶为靶点的抗癌先导化合物的发现国家科技部863课题(No2007AA02Z314)
摘    要:目的:寻找活性更好的类黄酮CDK s抑制剂。方法:利用M ann ich反应制备7个查尔酮类类黄酮。结果:目标化合物的结构经过IR、1H-NMR、ESI-MS确证,并测定了化合物对CDK1的抑制活性以及对HCT116的体外抗肿瘤活性。结论:其中有3个化合物对CDK1的抑制活性高于对照F lavop iridol,所有化合物对HCT116显示较强的抑制活性。

关 键 词:查尔酮  CDK1抑制活性  体外抗肿瘤活性

The Synthesis and Anticancer Activity Study of Flavonoids as CDK Inhibitors
LI Yanling,FANG Hao,XU Wenfang.The Synthesis and Anticancer Activity Study of Flavonoids as CDK Inhibitors[J].Journal of Baotou Medical College,2011,27(4):12-14.
Authors:LI Yanling  FANG Hao  XU Wenfang
Institution:LI Yanling(1,2),FANG Hao1,XU Wenfang1(1.School of Pharmacy,Shandong University,Ji'nan 250012,China,2.Baotou Medical College)
Abstract:Objective: To search flavonoids with higher CDK inhibitive ability.Methods: Chalcone route was applied to synthesize 7 chalcones.Results: The structure of target compounds was confirmed by IR,1H-NMR and ESI-MS.The CDK1 inhibitive ability and the anticancer activity against HCT116 of the compounds were determined.Conclusion: The CDK1 inhibitive ability of three compounds is higher than flavopiridol,and all compounds demonstrate higher cytotoxicity activity against HCT116.
Keywords:Chalcones  CDK1 inhibitive ability  Anticancer activity  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号